Are patients with primary glomerular disease at increased risk of malignancy?

被引:2
|
作者
Han, Jialin [1 ]
Zhao, Yinshan [2 ]
Canney, Mark [3 ,4 ]
Atiquzzaman, Mohammad [1 ]
Keown, Paul [1 ]
Levin, Adeera [1 ,5 ]
Barbour, Sean [1 ,5 ]
机构
[1] Univ British Columbia, Dept Med, Div Nephrol, Vancouver, BC, Canada
[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[3] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[4] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[5] Prov Hlth Serv Author, BC Renal, Vancouver, BC, Canada
关键词
cancer; ESRD; glomerulonephritis; immunosuppression; kidney transplantation; CANCER INCIDENCE; SYSTEMIC-LUPUS; RHEUMATOID-ARTHRITIS; LYMPHOMA RISK; SKIN-CANCER; ASSOCIATION; THERAPY; METAANALYSIS; EXPOSURE; GLOMERULONEPHRITIS;
D O I
10.1093/ndt/gfad261
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Over the past decade, several observational studies and case series have provided evidence suggesting a connection between glomerular diseases and the development of malignancies, with an estimated risk ranging from 5 to 11%. These malignancies include solid organ tumours as well as haematologic malignancies such as lymphoma and leukaemia. However, these risk estimates are subject to several sources of bias, including unmeasured confounding from inadequate exploration of risk factors, inclusion of glomerular disease cases that were potentially secondary to an underlying malignancy, misclassification of glomerular disease type and ascertainment bias arising from an increased likelihood of physician encounters compared with the general population. Consequently, population-based studies that accurately evaluate the cancer risk in glomerular disease populations are lacking. While it is speculated that long-term use of immunosuppressive medications and glomerular disease activity measured by proteinuria and estimated glomerular filtration rate may be associated with cancer risk in patients with glomerular disease, the independent role of these risk factors remains largely unknown. The presence of these knowledge gaps could lead to a lack of awareness of cancer as a potential chronic complication of glomerular disease, underutilization of routine screening practices in clinical care that allow early diagnosis and treatment of malignancies and underrecognition of modifiable risk factors to decrease the risk of de novo malignancies over time. This review summarizes the current evidence on the risk of cancer in patients with glomerular diseases, explores the limitations of prior studies and discusses methodological challenges and potential solutions for obtaining accurate estimates of cancer risk and identifying modifiable risk factors unique to GN populations. 10.1093/ndt/gfad261 Video Watch the video of this contribution at https://academic.oup.com/ndt/pages/author_videos gfad261Media1 6344835995112
引用
收藏
页码:910 / 919
页数:10
相关论文
共 50 条
  • [1] Are patients with RA at increased risk of malignancy?
    Kimme L Hyrich
    Nature Clinical Practice Rheumatology, 2008, 4 : 632 - 633
  • [2] Are patients with RA at increased risk of malignancy?
    Hyrich, Kimme L.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (12): : 632 - 633
  • [3] Increased thyroid malignancy in patients with primary hyperparathyroidism
    Li, Luchuan
    Li, Baoyuan
    Lv, Bin
    Liang, Weili
    Zhang, Binbin
    Zeng, Qingdong
    Turner, Andrew G.
    Sheng, Lei
    ENDOCRINE CONNECTIONS, 2021, 10 (08) : 885 - 893
  • [4] Increased incidence of malignancy in patients with primary hyperparathyroidism
    Karakose, Melia
    Kocabas, Muhammet
    Can, Mustafa
    Caliskan Burgucu, Hatice
    Cordan, Ilker
    Kulaksizoglu, Mustafa
    Karakurt, Feridun
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (04) : 2023 - 2028
  • [5] MALIGNANCY RISK IS INCREASED IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Kasifoglu, T.
    Bilge, N. S. Yasar
    Yildiz, F.
    Ozen, G.
    Pehlivan, Y.
    Yilmaz, N.
    Tarhan, F.
    Yilmaz, S.
    Kucuk, A.
    Emmungil, H.
    Koca, S.
    Cinar, M.
    Korkmaz, C.
    Direskeneli, H.
    Arslantas, D.
    Erken, E.
    Can, G.
    Ozmen, M.
    Gonullu, E.
    Kisacik, B.
    Aksu, K.
    Karadag, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 655 - 655
  • [6] Multiple primary melanomas are associated with increased risk of internal malignancy
    Cai, E.
    Li, S.
    Swetter, S.
    Sarin, K. Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S206 - S206
  • [7] Patients with Early-Onset Colorectal Cancer Have an Increased Risk of Second Primary Malignancy
    Amelie Tiritilli
    Cynthia Ko
    Digestive Diseases and Sciences, 2022, 67 : 1328 - 1336
  • [8] Patients with Early-Onset Colorectal Cancer Have an Increased Risk of Second Primary Malignancy
    Tiritilli, Amelie
    Ko, Cynthia
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (04) : 1328 - 1336
  • [9] Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?
    Yates W.B.
    McCluskey P.J.
    Wakefield D.
    Journal of Ophthalmic Inflammation and Infection, 3 (1) : 1 - 9
  • [10] Risk of malignancy in patients with celiac disease
    Green, PHR
    Fleischauer, AT
    Bhagat, G
    Goyal, R
    Jabri, B
    Neugut, AI
    AMERICAN JOURNAL OF MEDICINE, 2003, 115 (03): : 191 - 195